Partner with Investors Who Understand the Science
We are technical investors — scientists first, investors second — who work closely with mission-driven teams at the edge of what’s possible.
What We Look For:
U.S.-based companies with roots in world-class research (Stanford, MIT, UCSF, Harvard, etc.)
Strong technical IP with clear regulatory or clinical pathways
Pre-seed or seed-stage, sub-$25M post-money
Categories: Neural Interfaces, AI for Biology, Human Augmentation, Computational Diagnostics
Founders who value precision, narrative discipline, and true partnership
How We Work with Neurotech Founders:
Practical support in shaping your capital strategy, refining your narrative, and building meaningful partnerships
Access to a trusted network of investors, family offices, and technical operators who understand your space
A collaborative partner who can bridge the gaps between scientific innovation, business needs, and market dynamics